Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer
Journal of Clinical Oncology | Feb 12, 2019
Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus: The HIJ-CREATE sub-study
Diabetes Research and Clinical Practice | Feb 12, 2019
Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA
Respiratory Medicine | Feb 12, 2019
Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment
European Journal of Internal Medicine | Feb 12, 2019
Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial
Journal for ImmunoTherapy of Cancer | Feb 12, 2019
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes
Diabetes, Obesity and Metabolism | Feb 12, 2019